In contrast, the GAA2 group exhibited predominant alterations in glycerophospholipid metabolism, choline metabolism in cancer, citrate cycle (TCA cycle), sphingolipid metabolism, cAMP signaling pathway, glucagon signaling pathway, and tyrosine metabolism. The gene discussed is GCG; the disease is cancer.